IBM, WellPoint and Memorial Sloan-Kettering Cancer Center have announced what they say are the first commercially developed applications based on IBM's Watson technology. They include an advanced clinical decision support system for oncologists, and tools designed to accelerate and streamline the prior authorization process at health plans.
IBM Watson helps doctors fight cancer
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content